Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-01T02:07:53.516Z Has data issue: false hasContentIssue false

14 - Neuroimmunology and immune-related neuropathologies

Published online by Cambridge University Press:  04 November 2009

Bao-Guo Xiao
Affiliation:
Department of Neurology Karolinska Institute and Huddinge University Hospital M 98, 14186 Huddinge Stockholm Sweden
Hans Link
Affiliation:
Department of Neurology Karolinska Institute and Huddinge University Hospital M 98, 14186 Huddinge Stockholm Sweden
Turgut Tatlisumak
Affiliation:
Helsinki University Central Hospital
Marc Fisher
Affiliation:
University of Massachusetts Medical School
Get access

Summary

Basic immunology

Systemic immunology

Immunology is a relatively new and rapidly developing field that is involved in most clinical diseases. In 1796, Edward Jenner discovered that cowpox or vaccinia induced protection against human smallpox, but he knew nothing of the infectious agents that cause disease. Late in the nineteenth century, Robert Koch proved that infectious diseases are caused by microorganisms. We now recognize four broad categories of disease-causing microorganisms or pathogens: viruses, bacteria, fungi, and parasites. In 1890, Emil von Behring and Shibasaburo Kitasato discovered that the serum of vaccinated individuals contained antibodies that specifically bound to the relevant pathogen. Both innate and adaptive immune responses depend on the activities of leukocytes.

The immune system is a complex network of specialized cells and organs that defend the body against foreign pathogens and maintain the balance between immunity and tolerance. The peripheral lymphoid organs (lymph node and spleen) are specialized to trap antigen and allow the initiation of adaptive immune responses. Once lymphocytes are mature, they leave the central lymphoid organs (thymus and bone marrow), and are capable of responding to foreign pathogens. Peripheral mature immune cells include lymphocytes (T cells and B cells), antigen presenting cells (macrophages and dendritic cells, DC) and nature killer (NK) cells. Armed effector T cells play a critical role in almost all adaptive immune responses. Both major histocompatibility complex (MHC) and co-stimulatory signals provided by professional antigen-presenting cells (APC) are required for the activation and expansion of T cells.

Type
Chapter
Information
Handbook of Experimental Neurology
Methods and Techniques in Animal Research
, pp. 212 - 238
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allen, DD, Lockman, PR. The blood–brain barrier choline transporter as a brain drug delivery vector. Life Sci. 2003, 73: 1609–1615.CrossRefGoogle ScholarPubMed
Xiao, BG, Xu, LY, Yang, JS. TGF-beta 1 synergizes with GM-CSF to promote the generation of glial cell-derived dendriform cells in vitro. Brain Behav. Immun. 2002, 16: 685–697.CrossRefGoogle ScholarPubMed
Schwartz, M. Macrophages and microglia in central nervous system injury: are they helpful or harmful? J. Cereb. Blood Flow Metab. 2003, 23: 385–394.CrossRefGoogle ScholarPubMed
Fischer, HG, Reichmann, G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 2001, 166: 2717–2726.CrossRefGoogle ScholarPubMed
Aloisi, F, Penna, G, Polazzi, E, et al. CD40–CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J. Immunol. 1999, 162: 1384–1391.Google Scholar
Dong, Y, Benveniste, EN. Immune function of astrocytes. Glia 2001, 36: 180–190.CrossRefGoogle ScholarPubMed
Dietrich, PY, Walker, PR, Saas, P. Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation? Neurology 2003, 60: 548–554.CrossRefGoogle ScholarPubMed
Neumann, H. Control of glial immune function by neurons. Glia 2001, 36: 191–199.CrossRefGoogle ScholarPubMed
Flugel, A, Schwaiger, FW, Neumann, H, et al. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 2000, 10: 353–364.CrossRefGoogle ScholarPubMed
Buntinx, M, Stinissen, P, Steels, P, et al. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. Crit. Rev. Immunol. 2002, 22: 391–424.CrossRefGoogle ScholarPubMed
Bechmann, I, Steiner, B, Gimsa, U, et al. Astrocyte-induced T cell elimination is CD95 ligand dependent. J. Neuroimmunol. 2002, 132: 60–65.CrossRefGoogle ScholarPubMed
Noseworthy, JH, Lucchinetti, C, Rodrigez, M, et al. Multiple sclerosis. New Engl. J. Med. 2000, 343: 938–952.CrossRefGoogle ScholarPubMed
Haas, J, Storch-Hagenlocher, B, Biessmann, A, et al. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1–42 in vitro. Neurosci. Lett. 2002, 322: 121–125.CrossRefGoogle ScholarPubMed
Suter, T, Biollaz, G, Gatto, D, et al. The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. Eur. J. Immunol. 2003, 33: 2998–3006.CrossRefGoogle ScholarPubMed
Weiner, HL, Selkoe, DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature 2002, 420: 879–884.CrossRefGoogle ScholarPubMed
Reina, MA, Lopez, A, Villanueva, MC, et al. [The blood–nerve barrier in peripheral nerves.] Rev. Esp. Anestesiol. Reanim. 2003, 50: 80–86. (In Spanish)Google ScholarPubMed
Tabuchi, T, Nakao, Y, Sakihama, N, et al. Vascular permeability to fluorescent substance in human cranial nerves. Ann. Otol. Rhinol. Laryngol. 2002, 111: 736–737.CrossRefGoogle ScholarPubMed
Hirakawa, H, Okajima, S, Nagaoka, S, et al. Loss and recovery of the blood–nerve barrier in the rat sciatic nerve after crush injury are associated with expression of intercellular junctional proteins. Exp. Cell Res. 2003, 284: 196–210.CrossRefGoogle ScholarPubMed
Lilje, O. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol. Life Sci. 2002, 59: 2191–2198.CrossRefGoogle ScholarPubMed
Hadden, RD, Gregson, NA, Gold, R, et al. Accumulation of immunoglobulin across the ‘blood–nerve barrier’ in spinal roots in adoptive transfer experimental autoimmune neuritis. Neuropathol. Appl. Neurobiol. 2002, 28: 489–497.CrossRefGoogle ScholarPubMed
Keswani, SC, Polley, M, Pardo, CA, et al. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann. Neurol. 2003, 54: 287–296.CrossRefGoogle ScholarPubMed
Molina-Holagado, E, Arevalo-Martin, A, Vela, JM, et al. [Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms.] Rev. Neurol. 2002, 35: 973–978. (In Spanish)Google Scholar
Xiao, BG, Diab, A, Zhu, J, et al. Astrocytes induce hyporesponses of myelin basic protein-reactive T and B cell function. J. Neuroimmunol. 1998, 89: 113–121.CrossRefGoogle Scholar
Xu, LY, Yang, JS, Xiao, BG. TGF-beta1-conditioned glial cell-derived dendritic cells inhibit expansion of MBP-reactive T cells in vitro. NeuroReport 2002, 13: 35–39.CrossRefGoogle ScholarPubMed
Litzenburger, T, Fassler, R, Bauer, J, et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 1998, 188: 169–180.CrossRefGoogle ScholarPubMed
Mead, RJ, Singhrao, SK, Neal, JW, et al. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J. Immunol. 2002, 168: 458–465.CrossRefGoogle ScholarPubMed
Calida, DM, Constantinescu, C, Purev, E, et al. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice. J. Immunol. 2001, 166: 723–726.CrossRefGoogle Scholar
Weerth, SH, Rus, H, Shin, ML, et al. Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am. J. Pathol. 2003, 163: 1069–1080.CrossRefGoogle ScholarPubMed
Zhang, GX, Ma, CG, Xiao, BG, et al. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats. Eur. J. Immunol. 1995, 25: 1191–1198.CrossRefGoogle ScholarPubMed
Zhang, GX, Xiao, BG, Bakhiet, M, et al. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis. J. Exp. Med. 1996, 184: 349–356.CrossRefGoogle ScholarPubMed
Zhang, GX, Xiao, BG, Yu, LY, et al. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. J. Neuroimmunol. 2001, 113: 10–18.CrossRefGoogle Scholar
Saoudi, A, Bernard, I, Hoedemackers, A, et al. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. J. Immunol. 1999, 162: 7189–7197.Google ScholarPubMed
Mackay, F, Mackay, CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 2002, 23: 113–115.CrossRefGoogle ScholarPubMed
Mariette, X, Roux, S, Zhang, J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 2003, 62: 168–171.CrossRefGoogle ScholarPubMed
Xiao, BG, Duan, RS, Link, H, et al. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells. Cell Immunol. 2003, 223: 63–69.CrossRefGoogle ScholarPubMed
Lin, F, Kaminski, HJ, Conti-Fine, BM, et al. Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. J. Clin. Invest. 2002, 110: 1269–1274.CrossRefGoogle ScholarPubMed
Clayton, A, Harris, CL, Court, J, et al. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 2003, 33: 522–531.CrossRefGoogle ScholarPubMed
Evoli, A, Tonali, PA, Padua, L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003, 126: 2304–2311.CrossRefGoogle ScholarPubMed
Vincent, A, McConville, J, Farrugia, ME, et al. Antibodies in myasthenia gravis and related disorders. Ann. NY Acad. Sci. 2003, 998: 324–335.CrossRefGoogle ScholarPubMed
Racke, MK, Ratts, RB, Arredondo, L, et al. The role of co-stimulation in autoimmune demyelination. J. Neuroimmunol. 2000, 107: 205–215.CrossRefGoogle Scholar
Cannella, B, Gaupp, S, Tilton, RG, et al. Differential efficacy of a synthetic antagonist of VLA-4 during the course of chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2003, 71: 407–416.CrossRefGoogle ScholarPubMed
Yarilin, D, Duan, R, Huang, YM, et al. Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis. Clin. Exp. Immunol. 2002, 127: 214–219.CrossRefGoogle ScholarPubMed
Xiao, BG, Wu, XC, Yang, JS, et al. Therapeutic potential of IFN-gamma-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis. Int. Immunol. 2004, 16: 13–22.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×